Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility – a prospective, translational study

Glioblastoma (GBM) is an incurable brain tumor for which new treatment strategies are urgently needed. Next‐generation sequencing of GBM has most often been performed retrospectively and on archival tissue from both diagnostic and relapse surgeries with limited knowledge of clinical information, inc...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Dorte S. Nørøxe, Christina W. Yde, Olga Østrup, Signe R. Michaelsen, Ane Y. Schmidt, Savvas Kinalis, Mathias H. Torp, Jane Skjøth‐Rasmussen, Jannick Brennum, Petra Hamerlik, Hans S. Poulsen, Finn C. Nielsen, Ulrik Lassen
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2020-11-01
Saila:	Molecular Oncology
Gaiak:	chromosomal instability genomic profiling newly diagnosed glioblastoma NTRK fusion translational relevance tumor mutational burden
Sarrera elektronikoa:	https://doi.org/10.1002/1878-0261.12790
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!